POET-SHIELD
Summary
The POET-SHIELD study collects detailed information about participants' cancer biology, health, and lifestyle. By collecting biological samples, we will be able to conduct molecular analysis on these samples to determine targets for treatment and how these targets may change during treatment, or at recurrence and progression of disease. Identifying potential molecular targets can greatly impact the development of new treatments in hopes of improving survival outcomes for cancer patients.
Through the POET-SHIELD study, the POET Program will play a key role in developing a personalized approach to treatment planning as well as facilitating the timely adoption of new therapies.
If you choose to participate, your information will be pooled with a very large group of other cancer patients in Alberta. Through this program, we aim to benefit the scientific community through access to clinical data and biological samples for research purposes in hopes of improving treatments and survival outcomes for cancer patients within the community.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 18 to 100
Inclusion criteria:
In order to participate in the study, you must satisfy all of the following eligibility criteria:
1) Pathologically or clinically confirmed diagnosis of cancer.
2) Be at least 18 years of age.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
For more information, or to join the study, please contact Tracy Xu at tracy.xu@ahs.ca
Principal investigator:
Steven Yip
Clinical trial:
No
REB-ID:
HREBA.CC-16-0956